0
0
0
Disaster and Emergency Pricing Abuse Prevention Act
2/9/2022, 12:41 AM
Congressional Summary of S 3576
Disaster and Emergency Pricing Abuse Prevention Act
This bill prohibits a person from selling or offering for sale an essential good or service at a price that is unconscionably excessive during, or in anticipation of, a state of emergency or natural disaster. Additionally, the bill establishes a telephone hotline to receive complaints from the public about potential violations of this prohibition.
Read the Full Bill
Current Status of Bill S 3576
Bill S 3576 is currently in the status of Bill Introduced since March 24, 2020. Bill S 3576 was introduced during Congress 116 and was introduced to the Senate on March 24, 2020. Bill S 3576's most recent activity was Read twice and referred to the Committee on Commerce, Science, and Transportation. as of March 24, 2020
Bipartisan Support of Bill S 3576
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
3Democrat Cosponsors
3Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 3576
Primary Policy Focus
CommercePotential Impact Areas
- Civil actions and liability
- Consumer affairs
- Emergency medical services and trauma care
- Government information and archives
- Infectious and parasitic diseases
- Inflation and prices
- Natural disasters
Alternate Title(s) of Bill S 3576
Disaster and Emergency Pricing Abuse Prevention Act
Disaster and Emergency Pricing Abuse Prevention Act
A bill to clarify that the Federal Trade Commission Act prohibits excessive and unjustified price increases in the sale of certain products and services when an emergency or disaster results in abnormal disruptions of the market, and for other purposes.
Comments
Sponsors and Cosponsors of S 3576
Latest Bills
Strengthening America’s Turning Point Act
Bill S 1518July 26, 2026
Unlocking Native Lands and Opportunities for Commerce and Key Economic Developments Act of 2025
Bill S 3383July 25, 2026
To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
Bill HR 3029July 25, 2026
Transparency in Billing Act of 2026
Bill HR 8684July 25, 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Bill S 4472July 25, 2026
Connected Vehicle Security Act of 2026
Bill S 4429July 25, 2026
Protecting American Taxpayers Act
Bill S 4952July 25, 2026
National Defense Authorization Act for Fiscal Year 2027
Bill S 4784July 25, 2026
Renewing the African American Civil Rights Network Act
Bill S 4767July 25, 2026
National Plan for Epilepsy Act
Bill S 494July 25, 2026



